A49.02
Methicillin resistant Staphylococcus aureus infection, unspecified site
Clinical Classification Guidelines
Inclusion Terms
- Methicillin resistant Staphylococcus aureus (MRSA) infection
Medical Intelligence & Overview
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that's resistant to many commonly used antibiotics, making it a challenging infection to treat. The condition designated by ICD-10 code A49.02 refers to an unspecified site of MRSA infection, meaning the infection can occur in various parts of the body. Recognizing and understanding MRSA infections are vital for effective management and prevention.
Causes & Symptoms
Clinical Causes: Contact with individuals infected with MRSA, especially if they have open wounds or skin infections. Sharing personal items such as towels, razors, or athletic equipment contaminated with bacteria. Healthy individuals can carry MRSA without symptoms, transmitting bacteria unknowingly. Hospital stays or healthcare procedures where infection control practices may be insufficient. Living in crowded or communal settings like dormitories or military barracks, which facilitate transmission. Weakening of the immune system due to other health conditions or treatments.
Key Symptoms: Redness, swelling, and tenderness at the infection site. Presence of pus or other drainage from a wound or skin lesion. Warmth around the infected area. Fever and chills in more severe cases. Skin rashes or boils that may appear suddenly. In bloodstream infections, symptoms include fatigue, rapid heartbeat, and low blood pressure. Infections in other organs may cause specific symptoms related to that area, such as urinary discomfort or respiratory issues.
Diagnostic & Treatment
Diagnosis Path: Diagnosing MRSA involves collecting samples from the suspected infection site, such as skin lesions or wounds, and growing bacteria in a laboratory to identify the strain and its antibiotic resistance. Additional tests, including blood cultures or imaging studies, might be necessary depending on the infection's severity and location. Surgeons or physicians use these results to determine the most appropriate treatment approach.
Treatment Protocols: Treatment of MRSA infections depends on the infection's location and severity. Common strategies include: - Antibiotic therapy: Using specific antibiotics that are effective against MRSA, such as vancomycin or linezolid. - Wound drainage: For abscesses or boils, procedures may be performed to drain pus and reduce bacterial load. - Supportive care: Rest, hydration, and pain management help in recovery. - Good hygiene practices: Regular handwashing and keeping wounds clean and covered to prevent spread. - In healthcare settings, strict infection control practices are vital to prevent outbreaks. Some MRSA infections may require hospitalization, especially if they involve blood, lungs, or other critical organs. The healthcare provider determines the best treatment plan tailored to each patient's needs.
Clinical Advice & FAQs
Billing Guidance
Is A49.02 a billable ICD-10 code?
Yes, A49.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A49.02?
Clinical documentation must specify the nature of Methicillin resistant Staphylococcus aureus infection, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
